Relapses were thought to drive disability progression with RRMS, but PIRA may be an important contributor, affecting patients ...
Blood biomarkers at disease onset may help predict relapse-associated worsening and progression independent of relapse ...
A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ... (RAW) and progression independent of relapse activity (PIRA).